At the time of writing, Agios Pharmaceuticals Inc [AGIO] stock is trading at $43.18, up 2.91%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AGIO shares have gain 2.59% over the last week, with a monthly amount glided 7.76%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Agios Pharmaceuticals Inc [NASDAQ: AGIO] stock has seen the most recent analyst activity on February 24, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $58. Leerink Partners downgraded its rating to a Market Perform and decreased its price target to $56 on September 27, 2024. Cantor Fitzgerald initiated its recommendation with a Overweight. Piper Sandler started tracking with a Overweight rating for this stock on February 03, 2023, and assigned it a price target of $41. In a note dated November 17, 2022, Goldman upgraded an Neutral rating on this stock and boosted its target price from $17 to $32.
For the past year, the stock price of Agios Pharmaceuticals Inc fluctuated between $23.42 and $62.58. Currently, Wall Street analysts expect the stock to reach $63.5 within the next 12 months. Agios Pharmaceuticals Inc [NASDAQ: AGIO] shares were valued at $43.18 at the most recent close of the market. An investor can expect a potential return of 47.06% based on the average AGIO price forecast.
Analyzing the AGIO fundamentals
According to Agios Pharmaceuticals Inc [NASDAQ:AGIO], the company’s sales were 40.88M for trailing twelve months, which represents an 44.57% jump. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -10.62%, Pretax Profit Margin comes in at -9.16%, and Net Profit Margin reading is -8.96%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.28 and Total Capital is -0.36. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 40.97 points at the first support level, and at 38.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 44.60, and for the 2nd resistance point, it is at 46.02.
Ratios To Look Out For
It is important to note that Agios Pharmaceuticals Inc [NASDAQ:AGIO] has a current ratio of 14.48. Further, the Quick Ratio stands at 14.04, while the Cash Ratio is 1.24. Considering the valuation of this stock, the price to sales ratio is 61.37, the price to book ratio is 1.83 and price to earnings (TTM) ratio is 3.91.
Transactions by insiders
Recent insider trading involved SARAH GHEUENS, Officer, that happened on Oct 30 ’25 when 200.0 shares were purchased. Chief Medical Officer, Gheuens Sarah completed a deal on Oct 27 ’25 to sell 3302.0 shares. Meanwhile, Officer SARAH GHEUENS bought 3302.0 shares on Oct 27 ’25.
